 |
|
Recommendation for use of a long-acting monoclonal antibody to prevent respiratory syncytial virus infection in infants and young children
Soo-Han Choi, Dong Hyun Kim, Jong Gyun Ahn, Ki Wook Yun, Byung-Wook Eun, Jin Lee, Jina Lee, Taek-Jin Lee, Hyunju Lee, Dae Sun Jo, Eun Young Cho, Hye-Kyung Cho, Young June Choe, Ui Yoon Choi, Yun-Kyung Kim,
Clin Exp Pediatr. 2025;68(10):742-750. Published online 2025 Sep 3 DOI: https://doi.org/10.3345/cep.2025.01067
|
|
Citations to this article as recorded by
 RESPIRIAMO – Italian hospital surveillance for lower respiratory tract infections: a multicenter retrospective cohort study of respiratory syncytial virus-associated hospitalizations in children under 2 years of age
Elena Bozzola, Emanuela Piccotti, Enza D’Auria, Sandra Trapani, Anna Chiara Vittucci, Francesca Tirelli, Susanna Esposito, Diego Peroni, Antonietta Giannattasio, Giovanni Corsello, Raffaella Nenna, Raffaele Badolato, Alessandra Coscia, Anna Benedetta Del
BMC Pediatrics.2026;[Epub] CrossRef Effectiveness of Nirsevimab in High-Risk Children Under 24 Months for Prevention of Respiratory Syncytial Virus Infection: A Systematic Review and Meta-Analysis
Ye Kyung Kim, Erdenetuya Bolormaa, Ui Yoon Choi, Hyun Mi Kang, Ji-Man Kang, Joon-sik Choi, Ki Wook Yun, Byung Ok Kwak, Seung-Ah Choe, Young June Choe, Jin Lee, Soo-Han Choi, Yun-Kyung Kim
Journal of Korean Medical Science.2026;[Epub] CrossRef
|